December 08 was a positive day for Valeant Pharmaceuticals International Inc. (VRX:CA) as its stock finished the day having gained 11.82% to hit a price of $25.36 a share. The company reached a market cap of 8.83 billion and has 348.26 million shares outstanding. Valeant Pharmaceuticals International Inc. is a component of the the S&P/TSX Composite Index.
4.48 million shares changed hands over the course of the day as compared to an average volume of 2.15 million over the last 30 days for Valeant Pharmaceuticals International Inc..
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.. The company makes its home in Laval, QC, and is currently under the leadership of CEO Joseph C. Papa.
Valeant Pharmaceuticals International Inc. has hit a high of $23.75 and reached a low of $11.20 over its last year of trading. The stock’s 50-day SMA is now $18.13 and 200-day SMA is $17.50. As for its price valuations, the P/E ratio is at 3 and P/B is now 1.3.
Launched in 1977, the S&P/TSX Composite Index is widely recognized as the benchmark gauge for the broader Canadian equity market. According to TMX, the index cover approximately 95% of the Canadian equities market and only Canadian-based companies listed on the Toronto Stock Exchange are eligible to be included in the index.